Maximilian Rabil, MD
Cards
About
Research
Publications
2026
Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States.
Leapman M, Long J, Westvold S, Rabil M, Sprenkle P, Kim I, Spilberg G, Saperstein L, Fallah J, Suzman D, Lerro C, Xu J, Rivera D, Kluetz P, Karnes R, Dinan M, Mitchell A, Kunst N, Wang S, Ma X, Gross C. Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States. JCO Oncology Practice 2026, op2500617. PMID: 41632928, DOI: 10.1200/op-25-00617.Peer-Reviewed Original ResearchThis study investigates the rapid adoption of PSMA-PET imaging for prostate cancer in the U.S., highlighting increased usage since 2021 and disparities based on income and education.Prostate cancer deaths will decrease by 2050
Brutus N, Rabil M, Kim I. Prostate cancer deaths will decrease by 2050. Urologic Oncology Seminars And Original Investigations 2026, 44: 110971. PMID: 41500928, DOI: 10.1016/j.urolonc.2025.12.007.Peer-Reviewed Original Research
2025
Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer Evaluation
Kunst N, Long J, Sprenkle P, Kim I, Saperstein L, Rabil M, Ghaffar U, Karnes R, Ma X, Gross C, Wang S, Leapman M. Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer Evaluation. JAMA Network Open 2025, 8: e2539250. PMID: 41134573, PMCID: PMC12552925, DOI: 10.1001/jamanetworkopen.2025.39250.Peer-Reviewed Original ResearchHarmonizing environmental and economic forces in urologic care
Rabil M, Choksi A, Leapman M. Harmonizing environmental and economic forces in urologic care. Current Opinion In Urology 2025, 35: 679-684. PMID: 40948360, DOI: 10.1097/mou.0000000000001338.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsAutomated electronic medical record abstraction algorithm for radical prostatectomy outcomes
Rabil M, Jalfon M, Palencia P, Heckscher D, Kong V, Golos A, Richmond R, Chess A, Kim I, Leapman M, Cavallo J. Automated electronic medical record abstraction algorithm for radical prostatectomy outcomes. Urologic Oncology Seminars And Original Investigations 2025, 43: 710.e1-710.e8. PMID: 40885622, DOI: 10.1016/j.urolonc.2025.07.028.Peer-Reviewed Original ResearchKappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant
Mayer F, Stewart A, Varman D, Moritz A, Foster J, Owens A, Areal L, Gowrishankar R, Velez M, Wickham K, Phelps H, Katamish R, Rabil M, Jayanthi L, Vaughan R, Daws L, Blakely R, Ramamoorthy S. Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant. Molecular Psychiatry 2025, 30: 4651-4664. PMID: 40442453, PMCID: PMC12436197, DOI: 10.1038/s41380-025-03055-4.Peer-Reviewed Original ResearchProstate-Specific Membrane Antigen Imaging Findings and Subsequent Clinical Management Among Patients With Biochemically Recurrent Prostate Cancer
Rabil M, Ghaffar U, Long J, Westvold S, Sprenkle P, Kim I, Saperstein L, Kunst N, Wang S, Ma X, Gross C, Leapman M, Karnes R. Prostate-Specific Membrane Antigen Imaging Findings and Subsequent Clinical Management Among Patients With Biochemically Recurrent Prostate Cancer. JU Open Plus 2025, 3 DOI: 10.1097/ju9.0000000000000278.Peer-Reviewed Original ResearchPost-vasectomy semen analysis: what is the best protocol?
Cahill E, Rabil M, Rotker K, Honig S. Post-vasectomy semen analysis: what is the best protocol? International Journal Of Impotence Research 2025, 1-5. PMID: 40155486, DOI: 10.1038/s41443-025-01052-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsDiscrepancies in volume: impact of Artemis segmented magnetic resonance imaging, ultrasound, and ExactVu measurements on prostate specific antigen density and National Comprehensive Cancer Network risk stratification
Rabil M, Webb L, Diaz G, Lokeshwar S, Choksi A, Sprenkle P. Discrepancies in volume: impact of Artemis segmented magnetic resonance imaging, ultrasound, and ExactVu measurements on prostate specific antigen density and National Comprehensive Cancer Network risk stratification. Central European Journal Of Urology 2025, 78: 1-4. PMID: 40371423, PMCID: PMC12073516, DOI: 10.5173/ceju.2024.0249.Peer-Reviewed Original Research
2024
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI
Sundaresan V, Webb L, Rabil M, Golos A, Sutherland R, Bailey J, Rajwa P, Seibert T, Loeb S, Cooperberg M, Catalona W, Sprenkle P, Kim I, Leapman M. Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI. Urologic Oncology Seminars And Original Investigations 2024, 43: 193.e19-193.e26. PMID: 39706698, DOI: 10.1016/j.urolonc.2024.11.007.Peer-Reviewed Original Research
News
News
- July 27, 2026
Yale Urology 2026 Bernard Lytton Visiting Professor Day and Graduation
- March 09, 2026
Prostate Cancer Deaths to Decrease, Yale Researchers Predict
- October 27, 2025
Yale Urology Research
- July 29, 2025
Yale Urology Research [Q2: April-June 2025]